Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Levemir

PharmaCompass

01

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,143

2019 Revenue in Millions : 1,514

Growth (%) : -24

blank

02

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 865

2020 Revenue in Millions : 1,124

Growth (%) : -19

blank

03

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 668

2021 Revenue in Millions : 865

Growth (%) : -23

blank

04

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2023 Revenue in Millions : 572

2022 Revenue in Millions : 668

Growth (%) : -14

blank

05

Brand Name : Levemir

Insulin Detemir\n

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir\n

Main Therapeutic Indication : Diabetes

Currency : USD

2016 Revenue in Millions : 2,392

2015 Revenue in Millions : 2,562

Growth (%) : -7

blank

06

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2017 Revenue in Millions : 2,400

2016 Revenue in Millions : 2,904

Growth (%) : -17

blank

07

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2018 Revenue in Millions : 1,679

2017 Revenue in Millions : 2,118

Growth (%) : -21%

blank

08

Brand Name : Levemir

Insulin Detemir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Levemir

arrow
2024 ACI Convention
Not Confirmed

Insulin Detemir

Main Therapeutic Indication : Diabetes

Currency : USD

2019 Revenue in Millions : 1,396

2018 Revenue in Millions : 1,679

Growth (%) : -17

blank